Search

Your search keyword '"Ferrante, M"' showing total 2,497 results

Search Constraints

Start Over You searched for: Author "Ferrante, M" Remove constraint Author: "Ferrante, M"
2,497 results on '"Ferrante, M"'

Search Results

1. Patients with cancer who will be cured and projections of complete prevalence in Italy from 2018 to 2030

4. T.05.2: REDUCING DIAGNOSTIC DELAY OF EXTRA-INTESTINAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A COMPARATIVE STUDY BETWEEN A MULTIDISCIPLINARY IMMUNE-MEDIATED DISEASES OUTPATIENT CLINIC AND CONVENTIONAL REFERRAL SPECIALISTS

5. High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn’s Disease in a Randomized Placebo-Controlled Trial

6. Tracking the Spread of the BA.2.86 Lineage in Italy Through Wastewater Analysis

7. Chronic Antibiotic-Refractory Pouchitis: Management Challenges

9. OP05 Primary efficacy and safety of mirikizumab in moderate to severe Crohn’s Disease: results of the treat-through VIVID 1 study

11. OP35 Efficacy of mirikizumab in comparison to ustekinumab in patients with moderate to severe Crohn’s disease: Results from the phase 3 VIVID 1 study

12. DOP48 Faecal microbiota transplantation in active Ulcerative Colitis: Key lessons from a randomized controlled trial halted for futility

13. DOP53 Long-term Efficacy and Safety of Risankizumab in Patients With Moderate to Severe Crohn's Disease up to 3 Years of Treatment: Results From the FORTIFY Open-Label Long-term Extension

14. P593 Efficacy of Risankizumab in Patients With Moderately to Severely Active Ulcerative Colitis by Prior Advanced Therapy Failure and Mechanism of Action: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 Studies

15. P1128 Reducing diagnostic delay of Extra-Intestinal Manifestations in patients with Inflammatory Bowel Disease: a comparative study between a multidisciplinary immune-mediated diseases outpatient clinic and conventional referral specialists

16. DOP73 Early biological use in a Belgian, prospective inception cohort of patients with Inflammatory Bowel Disease: the PANTHER cohort

17. P1083 Patient preferences for Inflammatory Bowel Disease treatments: an international survey using a discrete choice experiment in partnership with EFCCA

21. OP06 Risankizumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomised Phase 3 COMMAND Study

23. DOP86 FOod Additives on the Mucosal barrier study (FOAM): Effect of five emulsifiers on inflammation, intestinal permeability, and the microbiome: preliminary results

24. P1009 Efficacy and safety of 4 years of continuous ozanimod treatment: an interim analysis of the True North open-label extension study

26. OP12 Mirikizumab improves fatigue, bowel urgency, and quality of life in patients with moderately to severely active Crohn’s Disease: Results from a phase 3 clinical trial

30. OP36 Risankizumab Versus Ustekinumab for the Achievement of Clinical Outcomes and Symptom Improvement in Patients With Moderate To Severe Crohn’s Disease: Results From the Phase 3b SEQUENCE Trial

31. DOP03 Gaps between ECCO quality standards of care and the real world: the E-QUALITY survey on processes and outcomes

34. DOP66 INSPIRE: Preliminary data from an observational post-marketing registry on the effectiveness and safety of darvadstrocel in patients with Crohn’s Disease and complex perianal fistulas

36. Platelet-Derived Microparticles (MPs) and Thrombin Generation Velocity in Deep Vein Thrombosis (DVT): Results of a Case–Control Study

37. From shallow to very shallow image of the highly active Kefalonia - Zakynthos fault system

41. Exploring Pediatric Secondary Osteoporosis: The Red Flag of Several Systemic Diseases.

42. PCR60 Shared Decision Making in Inflammatory Bowel Disease Clinical Practice: What Are the Experiences, Barriers, and Opportunities According to Patients and Healthcare Professionals?

Catalog

Books, media, physical & digital resources